Edgewise (EWTX) trade puts on 3000 December $40 / February $45 call diagonals at $1.85 debit, a name sideways since the big rip higher in September. The pipeline has multiple, near-term clinical readouts: sevasemten for Becker muscular dystrophy, or BMD, and Duchenne muscular dystrophy, or DMD, and EDG7500 for obstructive and non-obstructive hypertrophic cardiomyopathy, or HCM. Each are seen to have multi-billion dollar potential